Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - OTHER CURRENT LIABILITIES
Other Current Liabilities OCUL - Ocular Therapeutix, Inc.
28.7 M
LAST VALUE
24.49%
2 YEAR CAGR
35.86%
5 YEAR CAGR
44.13%
10 YEAR CAGR